Mostrando 9 resultados de: 9
Filtros aplicados
Área temáticas
Enfermedades(6)
Fisiología humana(4)
Bioquímica(3)
Medicina y salud(3)
Farmacología y terapéutica(2)
Abnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?
ArticleAbstract: Objective. Lipoprotein(a) is an independent risk factor for coronary artery disease. In Venezuela, LPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Arráiz N., Cano-Ponce C., Ciszek A., Faria J., Gotera D., Guerra-Torres X.E., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusExploratory study of the behavior of lipidic profile, malondialdehyde and nitric oxide in individuals of the Yukpa ethnic group from Zulian state, Venezuela
ArticleAbstract: Introduction: an abnormal lipidic profile is a risk indicator for cardiovascular diseases associatedPalabras claves:cardiovascular diseases, HDL, Lipidic profile, Malondialdehyde, Nitric oxideAutores:Acosta L., Amell A., Cano-Ponce C., Colmenares C., González M.C., Medina M.T., Nuñez M., Perez A., Rincón L., Seyfi H.A., Souki-Rincón A., Urribarri J., Valmore Bermúdez, Viloria A.Fuentes:scopusEpidemiological behavior of subclinical hypothyroidism and its association with cardiometabolic risk factors in adult Municipality Maracaibo, Venezuela
ArticleAbstract: Introduction: the relationship between subclinical hypothyroidism (HSC) and several cardiovascular rPalabras claves:Cardiovascular Risk Factors, diabetes mellitus, Metabolic syndrome, Subclinical hypothyroidism, TshAutores:Aguirre M.A., Añez-Ramos R., Cabrera M., Cano-Ponce C., Chávez C., David A., De M.C.G., González M.C., Gonzalez R., Iriarte N., Lubo A., Marulanda F., Miquilena E., Pachano F., París R., Paz P., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopusThe Maracaibo city metabolic syndrome prevalence study: Primary results and agreement level of 3 diagnostic criteria
ArticleAbstract: Objective: the purpose of this investigation was to determine the prevalence of Metabolic Syndrome (Palabras claves:Diagnostic criteria, Insulin Resistance, Low grade inflammation, Metabolic syndrome, obesityAutores:Añez-Ramos R., Calvo M.J., Cano-Ponce C., Chávez C., González M.C., Martínez M.S., Morillo J., Olivar L.C., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopus